Torrent Pharmaceuticals
| Formerly | Trinity Laboratories (1959–1971) |
|---|---|
| Type | Public |
| ISIN | INE685A01028 |
| Industry | Pharmaceuticals |
| Founded | 1959 |
| Founder | U. N. Mehta |
| Headquarters | Ahmedabad, Gujarat, India |
Area served | Worldwide |
| Key people | Sudhir Mehta (Chairman Emeritus) Samir Mehta (Chairman) Aman Mehta (Managing director) |
| Products | |
| Revenue | |
| Total assets | |
| Total equity | |
Number of employees | 12,881 (2020) |
| Parent | Torrent Group |
| Website | www.torrentpharma.com |
| Footnotes Financials as of 31 March 2025. | |
Torrent Pharmaceuticals Ltd, d/b/a Torrent Pharma, is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals operates in more than 40 countries with over 2,000 product registrations globally. Torrent Pharma is active in the therapeutic areas of cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective and pain management segments. It also has a presence in therapeutic segments of nephrology, oncology, gynecology, respiratory and pediatrics.